News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2% 7/31/2015
Novare Pharmaceuticals Announces The Issuance Of A U.S. Patent For Its RHAMM-Binding Peptides 7/30/2015
Cleave Biosciences Granted Key U.S. Patent Covering CB-5083 7/30/2015
Arcadia Biosciences (RKDA) Receives European Patent For Water Use Efficiency Trait Technology 7/29/2015
TWi Pharmaceuticals, Inc. Launches Generic MEGACE ES After Favorable Decision In Patent Suit 7/29/2015
Luxcath Awarded U.S. Patent For Real-Time Lesion Visualization Technology Focused On Atrial Fibrillation Ablation 7/29/2015
BioTelemetry, Inc. Announces Another Successful Patent Defense 7/28/2015
Spine Pain Management, Inc. Receives Final Patent From U.S. Patent Office For Its Quad Video Halo Along With Certification Update 7/28/2015
Inocucor Technologies Receives Groundbreaking U.S. Patent For Proprietary Biological Processes That Stimulate Plant Growth 7/28/2015
AbGenomics International Announces The Issuance By The USPTO Of A Patent Covering Its Antibody Drug Conjugate (ADC) Platform 7/28/2015
EyeGate Pharma Receives USPTO Notice Of Allowance For Proprietary Dexamethasone Phosphate Formulation 7/24/2015
Capstone Therapeutics (CAPS) Announces Patent Application For Novel, More Potent Chimeric Apo E Mimetic Peptides 7/23/2015
Pulmatrix Issued Patents Covering iSPERSE Technology For Treatment Of Patients With Inhaled Dry Powders 7/23/2015
ImmunID Key Technology Patents Covering ImmunTraCkeR And ImmunIG Granted In The United States, Europe, Canada And Japan 7/22/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Acceptance For Australian Patent For Key TB4 Peptide Fragment 7/22/2015
Therapeutics Solutions International, Inc. Release: Company Expands Immunotherapy Based Product Pipeline By Filing New Patent Application 7/22/2015
Advaxis, Inc. Expands Intellectual Property For Lm Technology Platform In HER2 7/21/2015
Deutsche Biotech Innovativ AG: Significant Strengthening Of The Patent Protection For The Sepsis Drug Candidate Adrecizumab 7/21/2015
Exco InTouch Granted United States Patent For Groundbreaking mDNA Technology 7/21/2015
ContraFect (CFRXU) Announces Issuance Of Key Patent Covering Novel Lysin Technology 7/20/2015
New Zealand Pharmaceuticals Assigns To Altamira Bio 7/20/2015
QT Vascular Announces The Allowance Of Four New Patents 7/15/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: U.S. PTO Issues Notice Of Allowance For Patent Using TB4 For Improving Neurological Outcomes After Injury And Neurodegenerative Disease 7/15/2015
Clean Hands Safe Hands Receives Patent For Hand Hygiene Technology 7/15/2015
Ocata Therapeutics Receives New U.S. Patent For Its RPE Therapy For Macular Degenerative Diseases 7/15/2015
Helius Medical Technologies Inventors Granted US Patent No. 9,072,889 7/15/2015
Cerespir Obtains New Patent From USPTO Covering The Optimal Synthetic Route For Commercial Manufacture Of CSP-1103 In Late Stage Development To Slow The Progression Of Mild Cognitive Impairment Due To Alzheimer's Disease 7/14/2015
Sequent Medical Inc. Awarded U.S. Patent For Innovative Implant Designs Using Composite Wire Technology 7/14/2015
Bioness Inc. Announces A Notification For Allowance From The U.S. Patent And Trademark Office For Stimrouter Neuromodulation System 7/14/2015
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s In China, Mexico And South Africa 7/13/2015
Patent Application For GenSpera Partner Phyton Biotech, Inc. Is Published By World Intellectual Property Organization (WIPO) 7/13/2015
Adamas Pharmaceuticals (ADMS) Issued U.S. Patent Relating To ADS-5102 Program 7/8/2015
Oculus Innovative Sciences, Inc. (OCLS) Receives New U.S. Patent For Microcyn Technology In Treatment Of Atopic Dermatitis 7/8/2015
Vital Art And Science Announces A New US Patent For Its Mvt Service For Age Related Macular Degeneration And Diabetic Retinopathy Patients 7/8/2015
Zecotek Photonics Inc. Granted Patent From Japanese Patent Office For Its 3D Display Technology 7/8/2015
Cortice Biosciences Announces Issuance Of A Key Patent Covering The Company's Alzheimer's Disease Drug Development Program 7/8/2015
Summit Therapeutics Granted Key Patent By European Patent Office For Utrophin Modulator SMT C1100 In The Treatment Of DMD 7/7/2015
Research Instruments Ltd Announces First European Patent For RI Witness System 7/6/2015
Auris Medical AG (EARS) Provides Update On U.S. Intellectual Property Portfolio 7/6/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing Of A New HETLIOZ Patent In The FDA Orange Book 7/2/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID(R) (Diclofenac Sodium Topical Solution) 2% 7/2/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice of Allowance For Two Additional U.S. Patents Covering RHB-104 Ongoing Phase III Crohn's Disease Program 7/1/2015
AVACEN Medical Patent Issued 7/1/2015
Kamada Ltd. (KMDA) Granted Key New Patent For Inhaled AAT And eFlow Nebulizer System In Israel 7/1/2015
Amarantus BioSciences, Inc. Announces Issuance Of United States Patent No. 9,066,903 Covering Proprietary Methods Of Administration Of Eltoprazine For The Treatment Of Parkinson's Disease 6/30/2015
ADMA Biologics, Inc. Receives Notice Of Allowance For U.S. Patent Pertaining To Its Lead Product Candidate RI-002 6/30/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Israel, Japan And South Africa 6/30/2015
Genervon Filed Patent For Using GM604 Modulations Of ALS Disease Biomarkers Showing Homeostasis, Leading To Prognosis And Therapeutic Treatment For ALS Disease 6/29/2015
Hemispherx Biopharma (HEB) Receives The European Patent Office Examining Division's Notice Of Intention To Grant The New Composition Of Matter Patent Covering Ampligen Formulations 6/25/2015
TAKE Solutions, Inc. Awarded Patent By USPTO 6/25/2015
DSX Therapeutics And R&D Antibodies Announce Issuance Of EU Patents For First-in-Class Monoclonal Antibody Based Sepsis Therapy 6/25/2015
Eli Lilly (LLY) Wins Patent Victory in UK Lawsuit 6/25/2015
Cesca Therapeutics Announces Issuance Of New U.S. Patent 6/23/2015
IGC Files Preliminary Phytocannabinoid Patent For Seizure Indication 6/23/2015
ISA Pharmaceuticals Further Strengthens IP Position On Lead Compound ISA101 6/23/2015
Gen9 Awarded Two Cornerstone Patents For BioFab DNA Assembly Technology 6/23/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid 6/23/2015
VG Life Sciences, Inc. (VGLS) Granted Combination Cancer Drug Patent 6/22/2015
Vaxon Biotech SA Granted Japanese Patent For New Cancer Vaccine Candidates 6/22/2015
InVivo Therapeutics (NVIV) Receives Notice Of Allowance On Patent Covering Broader Compositions For Neuro-Spinal Scaffold And Neuro-Spinal Scaffold Plus Stem Cells 6/22/2015
CellResearch Corporation Receives New US Patent Approval For Exclusive Stem Cell Technology Amidst New Partnerships 6/19/2015
U.S. Court of Appeals for the Federal Circuit Finds Teva (TEVA)'s '808 Copaxone Patent Invalid 6/18/2015
Onxeo Consolidates Its Industrial Property With A US Patent Protecting Validive Until 2029 6/18/2015
Momenta (MNTA) Announces CAFC Decision To Invalidate Remanded Teva (TEVA) Patent In Daily COPAXONE 20 Mg Suit 6/18/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Russia For Oral Administration Of GLP-1 6/16/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Israel, Macau And USA 6/16/2015
Biotage AB (BIOTa.ST) Continued Success In Re-Examination Proceedings 6/16/2015
Bionomics Limited (BNO.AX) Files Patent For Use Of BNC105 In Combination With PD-1 And CTLA-4 Immuno-Oncology Antibodies 6/15/2015
PTAB Invalidates Lucerne Biosciences' '813 Patent For The Treatment Of Binge Eating Disorder With Lisdexamfetamine Dimesylate 6/15/2015
DS Biopharma Announces Receipt Of Two Notices Of Allowance For U.S. Patent Applications Covering The Manufacture And Methods Of Use For Its Bioactive Compounds 6/15/2015
Provia Laboratories Bio-Banking Technology Achieves First Patent Approval 6/15/2015
Agile Therapeutics, Inc. Announces Issuance Of Patent For Twirla Patch Design 6/12/2015
Regen BioPharma Receives Notice Of Allowance For U.S. Patent For Screening Of Small Molecules Against Its Nuclear Receptor Target 6/12/2015
China Making Its Mark In Global Biopharma Patent Filings 6/11/2015
Can-Fite BioPharma (CFBI) Granted Notice Of Allowance For Patent Covering Manufacturing Process Of CF101 In The U.S. 6/10/2015
Melior Discovery Receives Patent Approval From U.S. Patent And Trademark Office For New Parkinson’s Disease Drug Candidate 6/10/2015
Next Up, Nanoplasmids: Nature Technology Corporation Granted Seven U.S. Patents 6/10/2015
Marina Biotech, Inc. (MRNA) Expands European And Canadian Patent Protection Of Its SMARTICLES Nucleic Acid Delivery Technology 6/10/2015
Keneric Healthcare Release: U.S. Patent & Trademark Office Rejects Hydrofera Patent 6/9/2015
Stempeutics Receives Japan Process Patent For Its Novel Stem Cell Drug 'Stempeucel' 6/8/2015
Collegium (COLL) Announces Issuance Of U.S. Patent Covering Deterx - An Abuse-Deterrent, Extended-Release Technology Platform 6/8/2015
Orexigen (OREX) And Takeda (TKPYY) File Lawsuit Against Actavis (ACT) For Infringement Of Contrave Patents 6/5/2015
Oxis Biotech Files U.S. Patent Application Covering p62/Sequestosome 1 Inhibitors For The Treatment Of Multiple Myeloma And Secondary Osteolytic Lesions 6/4/2015
Kit Check Announces Four Meaningful Patents 6/4/2015
Arno Therapeutics Announces Issuance Of First Onapristone Patent 6/4/2015
RXi Pharmaceuticals (RXII) Granted Notice Of Allowance For Patent Covering Lead Compound, RXI-109, For Use In The Eye 6/3/2015
Telesta Therapeutics Announces Issuance Of Key U.S. MCNA Composition Of Matter Patent 6/3/2015
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV734 6/2/2015
Ocata Therapeutics Receives Important New U.S. Patent For Its RPE Therapy For Macular Degenerative Diseases 6/2/2015
Pluristem Therapeutics (PSTI) Granted Key Cell Patents In Asia, Russia, Mexico, And Israel 6/1/2015
Prima Biomed (PRR.AX) Announces New IP For Its Lead IMP321 Development Program 5/29/2015
Cannabics Pharmaceuticals Inc. Files Patent Application Which Covers Novel Personalized Anti-Cancer Treatment 5/28/2015
Novogen Limited (NVGN) Release: ATM Technology Extended With New Patent Lodgement 5/28/2015
MediGene AG (MDGEF.PK): US Patent Office Prolongs Term Of Medigene's Patent Relating To Dendritic Cell (DC) Vaccines To 2031 5/28/2015
amp biosimilars AG Successfully Out-Licenses First Biosimilar 5/28/2015
Patent Covering The Use And Pharmaceutical Composition Of Isofol Medical AB’s Lead Drug Candidate, Modufolin, Allowed By United States Patent And Trademark Office 5/28/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of European Patent For Kerasal Nail 5/28/2015
OXiGENE (OXGN) Announces Issuance Of U.S. Patent For OXi4503 In Acute Myeloid Leukemia 5/27/2015
Ceres, Inc. Awarded Patent For Innovation In Soybean 5/27/2015
Regen BioPharma Files Patent Application On mRNA Dendritic Cell Cancer Immunotherapeutic 5/27/2015
InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 5/26/2015
Ocata Therapeutics Receives Three New U.S. Patents For Its RPE Therapy For Macular Degenerative Diseases 5/26/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Mexico And Singapore 5/22/2015
Highland Therapeutics Announces The Issuance Of Three U.S. Patents And One Notice Of Allowance 5/21/2015
I-MAK Release: Patent Challenges In Five Countries Dispute Validity Of Gilead (GILD)'s Claims To Hep C Drug Patents That Block Treatment For Up To 59 Million People 5/20/2015
Batu Biologics Files Patent On Blood Derived Anti-Cancer Immunomodulator 5/20/2015
Aphios Granted United States Patent For Alzheimer’s Disease Treatment 5/20/2015
Microlin Bio Announces Issuance Of Thirty Seven Additional Patents For The Use Of Microrna In Cancer Treatment And Diagnosis 5/19/2015
Hemostemix Receives Notice Of Allowance For Additional U.S. Patent On ACP-01 Covering Autologous Cell Therapy For Critical Limb Ischemia (CLI) 5/19/2015
New Patent Issued For Eagle Pharmaceuticals (EGRX)’ Bendamustine Rapid Infusion Product 5/19/2015
Auris Medical Holding AG Announces Notice Of Allowance From USPTO Related To Treating Middle Ear Diseases With Poloxamer-Based Fluoroquinolone Compositions 5/18/2015
Allegro Ophthalmics LLC Announces Issuance Of U.S. Patent For First-In-Class Integrin Peptide Therapy Candidate Luminate 5/18/2015
SanBio, Inc. Granted Key Patent In New Treatment For Chronic Stroke 5/15/2015
Hi-Tech Pharmaceutical Files Lawsuit Against The Third Most Litigious Patent Troll In America - Thermolife International And Ron Kramer - Sixty Six (66) Of Those Patents Were Licensed From Stanford University 5/14/2015
Suven Life Sciences Ltd Secures Two (2) Product Patents In Europe And Hong kong 5/13/2015
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Methods Of Administration And Compositions In The Treatment Of Parkinson's Disease 5/13/2015
Nevro Announces Filing Of Petitions For Inter Partes Review Of U.S. Patent No. 8,359,102 5/12/2015
Relmada Therapeutics Announces Notice Of Allowance For U.S. Patent Covering SECUREL(TM), Its Abuse-Deterrent, Extended-Release, Technology Platform For Opioids 5/12/2015
Immunomedics, Inc. (IMMU) Extends U.S. Patent Protection For Sacituzumab Govitecan To 2033 5/12/2015
Hi-Tech Pharmacal (HITK) Files Lawsuit Against Patent Troll With Ties To Stanford University - Thermolife International And Ron Kramer Sued Over Racketeer Influenced And Corrupt Organization Act (RICO) And Deceptive Trade Practices 5/12/2015
Domainex Ltd Announces The Grant Of US And European Patents For Its Lead Programme, Targeting IKK Epsilon And TBK1 For The Treatment Of Diseases Such As COPD And Psoriasis 5/11/2015
Arno Therapeutics Receives USPTO Notice Of Allowance For Two Important Patents Covering Lead Compound Onapristone 5/7/2015
Mati Therapeutics Expands Patent Portfolio 5/7/2015
New England Biolabs, Inc. Release: US Patent Awarded For Industry-Leading RNA-Seq Technology 5/6/2015
GenSpera Enters National Phase With Patent Application For Injectable Prodrug Formulations 5/6/2015
Pluristem Life Systems Inc. Granted European Patent For Use Of Cells To Help Treat Damaged Bone Marrow 5/6/2015
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use For MANF 5/5/2015
Provectus Biopharmaceuticals Inc.'s Novel Synthesis Patent Application Allowed By European Patent Office, Patent Issued By Japan 5/5/2015
Mylan (MYL) Confirms First-To-File Patent Challenge Relating To Minivelle 5/5/2015
NuGene International, Inc. Files Additional Patent Applications 5/4/2015
Vaccine Improvement Patent Awarded To iBio, Inc. (IBIO) 5/4/2015
Everything You Wanted to Know About Biosimilars But Were Afraid to Ask: An Expert Interview -- Part 2 4/30/2015
Summit Therapeutics Granted Key Patent For Novel Antibiotic SMT19969 For The Treatment Of C. Difficile Infection 4/30/2015
Sensory Neurostimulation Announces Issuance Of U.S. Patent For Relaxis™, The First And Only FDA -Cleared Non-Drug Treatment To Improve Sleep For Patients With Restless Legs Syndrome 4/30/2015
Everything You Wanted to Know About Biosimilars But Were Afraid to Ask: An Expert Interview 4/30/2015
Iroko Pharmaceuticals Granted New Patent For ZORVOLEX 4/29/2015
ProtoKinetix Inc. (PKTX.OB) Announces Acquisition Of Patents 4/28/2015
GenSpera Granted New Patent For Prodrugs Activated By Prostate Specific Antigen 4/28/2015
Advaxis, Inc. Enhances Lm-LLO Cancer Immunotherapy Intellectual Property Portfolio With Two USPTO Patents Addressing ADXS-PSA And ADXS-HER2 4/28/2015
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug 'Stempeucel' 4/27/2015
GW Pharmaceuticals (GWPH) Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy 4/27/2015
Forward Pharma (FWP) Receives Decision To Grant From EPO For DMF Patent In Europe 4/27/2015
Molecular Health Gains Patent For Novel Receptor Utilizing Computational Biomarker Discovery Technology 4/27/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering Pennsaid 2% 4/27/2015
Suven Life Sciences Ltd Secures Five (5) Product Patents For Their Nces In Australia, Europe, Hong Kong, Israel And Norway 4/24/2015
US Patent Granted For Batu Biologics Cancer Immunotherapeutic Product Immxcyte 4/23/2015
Probiodrug AG Release: Key Patents On Glutaminyl Cyclase (QC) Inhibition For The Treatment Of Alzheimer’s Disease Granted In Japan 4/23/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance For U.S. Patent For Healing And Reversing Heart And Coronary Vessel Damage After A Heart Attack With TB4 4/23/2015
Marina Biotech, Inc. (MRNA) Expands Global Patent Protection Of Clinical Stage Nucleic Acid Delivery Technologies 4/23/2015
Edico Genome Issued Broad Patent For DRAGENTM From United States Patent And Trademark Office 4/23/2015
CDEX Inc. (CDEX) Granted New Patent For Chemical And Molecular Identification And Quantification System Utilizing Enhanced Photoemission Spectroscopy 4/23/2015
SteadyMed (STDY) Granted Additional U.S. Patent With Patent Term Extension 4/22/2015
Ariad (ARIA) Announces Issuance Of Key U.S. Patent On Brigatinib 4/22/2015
Clearside Biomedical Announces Purchase Of Iscience Patent Portfolio For Suprachoroidal Space Drug Delivery 4/22/2015
IntelGenx Corp. Is Awarded Patent From The United States Patent And Trademark Office (USPTO) 4/22/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS (Prednisone) Delayed-Release Tablets 4/22/2015
ERYtech Pharma Strengthens Its Intellectual Property Position In The U.S. 4/21/2015
Pfizer (PFE) And Provectus Biopharmaceuticals Inc. Receive Patent Allowance For Use Of PV-10 In Combination With Systemic Immunotherapy Agents In Treatment Of Cancer 4/20/2015
Emotional Brain Obtains Patent Extension For Its Female Sexual Dysfunction Medication 4/17/2015
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID2% 4/17/2015
U.S. Patent Office Declares An Interference Between Forward Pharma (FWP) And Biogen (BIIB) Regarding The Treatment Of Multiple Sclerosis With 480 Mg Daily Dose Of DMF, The Active Ingredient In Tecfidera 4/16/2015
AEterna Zentaris (AEZS) Files Additional Patent Application To Strengthen IP Protection Of Zoptarelin Doxorubicin 4/16/2015
Medac Pharma, Inc. Announces Settlement Of Patent Infringement Lawsuits 4/16/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For Additional U.S. Patent For RHB-105 H. Pylori Bacterial Infection Treatment 4/16/2015
Mylan (MYL) Settles Patent Litigation Related To Viagra 4/14/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Trial Date For Fanapt Patent Cases 4/14/2015
Compumedics Limited (CMP.AX) (ASX:CMP) DWL New Patent Granted Underpinning Growth Opportunities 4/14/2015
ProtoKinetix Inc. (PKTX.OB) Announces Acquisition Of Patents 4/14/2015
Karyopharm Therapeutics (KPTI) Granted U.S. Composition-Of-Matter Patent For Selinexor (KPT-330) 4/13/2015
Evoke Pharma, Inc. Granted European Union Formulation Patent For EVK-001 4/9/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing Of A New Fanapt Patent In The FDA Orange Book 4/9/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering TCR-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/8/2015
USPTO Issues Key US Patent To TiGenix For The Use Of Adipose-Derived Stromal Cells In The Treatment Of Fistulas 4/8/2015
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015
Arena Pharmaceuticals, Inc. (ARNA) Receives Additional Patent For BELVIQ (lorcaserin HCl) From United States Patent And Trademark Office 4/7/2015
Particle Sciences Receives Patent For Its Surface Arrayed Therapeutics Drug Delivery Platform 4/7/2015
Regen BioPharma Expands Its Differentiation Therapy of Cancer Stem Cells Platform With Filing Of Patent Applications On Silencing Of NR2F2 4/7/2015
Eagle Pharmaceuticals (EGRX) Announces New Patent For Low-Sodium Bendamustine 4/7/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering Tcr-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/7/2015
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Sixth U.S. Patent Protecting Trokendi XR 4/3/2015
Cleveland Biolabs Inc. (CBLI) Announces New U.S. Composition Of Matter Patent For CBLB612 4/2/2015
Kamada Ltd. (KMDA) Receives Allowance For Key Canadian Patent For Large Scale Production And Use Of Proprietary Alpha-1 Proteinase Inhibitor 4/1/2015
Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride 4/1/2015
Meagan Medical Announces Issuance Of A Key U.S. Patent For A Disruptive Chronic Pain Treatment Using Spinal Cord Stimulation 4/1/2015
AmpliPhi Biosciences Corporation (APHB) Granted European Patent For Bacteriophage Therapy To Fight Biofilm-related Bacterial Infections 3/31/2015
Adamas Pharmaceuticals (ADMS) Issued Patent 3/31/2015
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015
OXIS International, Inc. (OXIS) Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh 3/26/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent Acceptance Notice For The Use Of TB4 To Prevent Tissue Damage Associated With Heart Attack And Stroke Treatments 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Grant Of EU Patent For MOB-015 Related To Topical Treatment Of Onychomycosis (Nail Fungus) 3/26/2015
Acasti Pharma Granted Composition & Use Patent In China 3/25/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent For Kerasal Nail 3/25/2015
Enzymotec Reports A Decision Of The U.S. Patent And Trademark Office 3/24/2015
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In India 3/24/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015
Highland Therapeutics Announces Receipt Of Two Notices Of Allowance For Patents On Lead Product 3/24/2015
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications 3/23/2015
Key TxCell Patent To Be Granted In The United States For Its Lead Product Ovasave 3/18/2015
Onxeo Consolidates Its Intellectual Property With The Grant Of New Patent Protection Of Validive In Japan Until 2029 3/18/2015



//-->